Trial Profile
A Phase 2 study of 2X-111 (2B3-101) in metastatic Breast Cancer
Status:
Planning
Phase of Trial:
Phase II
Latest Information Update: 06 Sep 2021
Price :
$35
*
At a glance
- Drugs Doxorubicin liposomal (Primary)
- Indications Advanced breast cancer
- Focus Therapeutic Use
- 04 Apr 2017 New trial record